XORTX Therapeutics (XRTX) Return on Assets [ROA] (2021 - 2026)
XORTX Therapeutics (XRTX) reported Return on Assets [ROA] of 8.59% for the quarter ended Jun 30, 2026, up 117.21 percentage points from -108.62% a year earlier but down 39.40 percentage points from the prior quarter.
Powered by 
Analysis
XORTX Therapeutics (XRTX) Return on Assets [ROA] (2021 - 2026) Analysis & Trends
For the year ended Dec 31, 2025, XORTX Therapeutics posted Return on Assets [ROA] of -78.38%, down 9.08 percentage points from the prior year.
- Return on Assets [ROA] has a five-year change of -179.94 percentage points (years ended Dec 2020 to Dec 2025).
- By year, Return on Assets [ROA] came in at -69.30% in the year ended Dec 31, 2024 (-45.11 pp), -24.19% in the year ended Dec 31, 2023 (+27.69 pp), -51.88% in the year ended Dec 31, 2022 (-38.07 pp) and -13.81% in the year ended Dec 31, 2021 (-115.37 pp).
- Five-year quarterly Return on Assets [ROA] spans a low of -108.62% in the quarter ended Jun 30, 2025 and a high of 47.99% in the quarter ended Mar 31, 2026.
- Year over year, Return on Assets [ROA] has now increased in each of the last three quarters, with an average year-over-year change of +24.75 percentage points over the last eight quarters.
- The high point for year-over-year Return on Assets [ROA] in five years was the quarter ended Jun 30, 2026 (a gain of 117.21 percentage points); the low point was the quarter ended Jun 30, 2025 (a drop of 83.54 percentage points).
- Per Business Quant data, the three quarters before the quarter ended Jun 30, 2026 came in at 47.99% (quarter ended Mar 31, 2026), -22.33% (quarter ended Dec 31, 2025) and -67.18% (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 20.64% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 10.47% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 4.65% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.45% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 28.37% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 9.10% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 9.29% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -6.13% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 2.14% |
| 10 | XORTX Therapeutics | 1.61 Mn | -1.69 Mn | - | 8.59% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.59% |
| Mar 31, 2026 | 47.99% |
| Dec 31, 2025 | -22.33% |
| Sep 30, 2025 | -67.18% |
| Jun 30, 2025 | -108.62% |
| Mar 31, 2025 | -61.36% |
| Dec 31, 2024 | -90.19% |
| Sep 30, 2024 | -20.86% |
| Jun 30, 2024 | -25.09% |
| Mar 31, 2024 | -55.96% |
| Dec 31, 2023 | -46.88% |
| Sep 30, 2023 | -102.99% |
| Jun 30, 2023 | -83.62% |
| Mar 31, 2023 | -75.12% |
| Dec 31, 2022 | -78.16% |
| Sep 30, 2022 | -66.54% |
| Jun 30, 2022 | -52.52% |
| Mar 31, 2022 | -29.28% |
| Dec 31, 2021 | -20.46% |
API Access
XORTX Therapeutics Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=XRTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "XRTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=XRTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();